Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan
· Delayed Price · Currency is TWD 297.50
-0.50 (-0.17%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Pharmaceuticals | 18.47B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Pharmaceuticals Growth | 9.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 115.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 22.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 115.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 22.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Other | 2.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 20.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 7.77B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 13.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea | 5.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | 2.25% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan | 2.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Taiwan Growth | 4.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 2.59B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | 20.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|